Geoffrey Colby
Neurological Surgery · Los Angeles, CANPI 1144373739
Payments from drug & device makers
Across 1,203 payments — averaging $935.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$660K
- Microvention, Inc.$288K
- Medtronic$93K
- Penumbra, Inc.$36K
- Rapid Medical Ltd$31K
- Medical Device Business Services, Inc.$7K
- plus $11K from 10 others
Across 14 payments — averaging $2206.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$27K
- Nuvascular Inc.$4K
What the payments were for
- Consulting fees$639,21259%
- Speaking & faculty fees$276,86926%
- Travel & lodging$139,42713%
- Food & beverage$24,7912%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 673 | $660,199 |
| Microvention, Inc. | 352 | $287,837 |
| Medtronic(2 entities) | 90 | $92,670 |
| Penumbra, Inc. | 11 | $36,171 |
| Rapid Medical Ltd | 35 | $30,762 |
| Medical Device Business Services, Inc. | 11 | $7,191 |
| Depuy Synthes Products, Inc. | 2 | $5,365 |
| Balt USA, LLC | 12 | $3,398 |
| Johnson & Johnson | 6 | $434 |
| Vascular Technology, Inc. | 1 | $400 |
| Phenox Inc. | 2 | $342 |
| Boston Scientific | 4 | $286 |
| Viz.ai, Inc. | 1 | $190 |
| Imperative Care, Inc | 1 | $181 |
| Corindus Inc. | 1 | $177 |
| Baxter Healthcare | 1 | $125 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SURPASS EVOLVE$269,058
- WEB Aneurysm Embolization System$176,617
- SURPASS$160,820
- WEB$96,941
- Pipeline$62,740
- TARGET$58,119
- NA$37,543
- TIGERTRIEVER 17 REVASCULARIZATION DEVICE$30,109
- COMANECI 17$25,909
- NEUROFORM EZ 3$20,894
- NEUROFORM ATLAS$19,242
- FLOWGATE$18,000
- INFINITY$14,225
- SYNCHRO$13,791
- 1488, IDEAL EYES$11,786
- TGS$11,700
- CITADEL$10,907
- AXS INFINITY LS$8,631
- EMBOGUARD$6,975
- EVOLVE PROLINE$6,782
How this compares
$1,125,728 in reported general payments places this provider in the 95th percentile of 773 neurological surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurological surgery in Los Angeles
- Larry KhooLos Angeles$3M
- Linda LiauLos Angeles$1.5M
- Aaron Cohen-GadolLos Angeles$1.3M
- Langston HollyLos Angeles$846K
- Carl LauryssenLos Angeles$710K
- Adam MamelakLos Angeles$678K
- Martin PhamLos Angeles$671K
- Vivek MehtaLos Angeles$528K
- Patrick HsiehLos Angeles$419K
- Gabriel ZadaLos Angeles$369K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.